EMA moves quickly to enforce clinical trial result reporting across Europe

The European Medicines Agency announced new measures aimed at ensuring that results of clinical trials are posted publicly in line with legal obligations.

The steps follow an analysis that found fewer than half of the studies listed in the Clinical Trial Information System were reported on time, and only 42% had complete results available.

Regulators said the actions will tighten oversight of the CTIS, which was launched in 2022 and now holds data on more than 8,400 mid- and late-stage trials across the EU and EEA.

Advocacy groups welcomed the rapid response, noting that stronger transparency could improve trust in medicines and support better decision-making for patients and investors.